Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 6/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 5/20 | 0.47 |
| ▸ | SRC | P12931 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.40 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | CPN1 | P15169 | 1/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
| ▸ | DRD1 | P21728 | 2/20 | 0.39 |
| ▸ | CA2 | P00918 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | PGR | P06401 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9702510 | 0.83 | ESR1 (0.50) | ESR1ESR2SRCLMNAHSD17B10 | |
| SCHEMBL1922327 | 0.83 | CYP2C19 (0.57) | SRCLMNAHSD17B10ALDH1A1CYP2C19 | |
| SCHEMBL7087165 | 0.81 | ESR1 (0.48) | ESR1ESR2SRCLMNAHSD17B10 | |
| SCHEMBL1118667 | 0.79 | TAAR1 (0.52) | ESR1ESR2SRCLMNAHSD17B10 | |
| SCHEMBL4795362 | 0.79 | ESR1 (0.47) | ESR1ESR2SRCLMNAHSD17B10 | |
| SCHEMBL819392 | 0.79 | LMNA (0.61) | ESR1ESR2SRCLMNAHSD17B10 | |
| SCHEMBL1118743 | 0.79 | TAAR1 (0.52) | ESR1ESR2SRCLMNAHSD17B10 | |
| SCHEMBL11248515 | 0.79 | PTGS1 (0.61) | ESR1ESR2SRCLMNAHSD17B10 | |
| SCHEMBL6461974 | 0.79 | L3MBTL1 (0.62) | ESR1ESR2SRCLMNAHSD17B10 | |
| SCHEMBL7040363 | 0.79 | ESR1 (0.47) | ESR1ESR2SRCLMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113402490-B | Preparation method of 1,2,6, 7-tetrahydro-8H-indeno [5,4-b ] furan-8-one | 白银京宇新药业有限公司 | 2023-01-03 | — | — | CN | disclosed |
| CN-113402490-A | Preparation method of 1,2,6, 7-tetrahydro-8H-indeno [5,4-b ] furan-8-one | 白银京宇新药业有限公司 | 2021-09-17 | — | — | CN | disclosed |
| EP-1783221-A1 | Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor | MIGENIX Corp. (US) | 2007-05-09 | — | — | EP | disclosed |
| US-7001729-B2 | Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor | MIGENIX CORP. (US) | 2006-02-21 | — | — | US | disclosed |
| US-6906175-B2 | Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor. | MIGENIX CORP. (US) | 2005-06-14 | — | — | US | disclosed |
| US-6902908-B2 | Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor | MIGENIX CORP. (US) | 2005-06-07 | — | — | US | disclosed |
| US-20050064530-A1 | PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR | MIGENIX CORP. | 2005-03-24 | — | — | US | disclosed |
| US-20050019835-A1 | PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR | MIGENIX CORP. | 2005-01-27 | — | — | US | disclosed |
| US-20050003353-A1 | PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR | MIGENIX CORP. | 2005-01-06 | — | — | US | disclosed |
| US-20050003352-A1 | PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR | MIGENIX CORP. | 2005-01-06 | — | — | US | disclosed |
| US-20040241801-A1 | Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor | MITOKOR, INC. | 2004-12-02 | — | — | US | disclosed |
| EP-1283884-A2 | PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR | MITOKOR (US) | 2003-02-19 | — | — | EP | disclosed |
| US-20010044144-A1 | Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor | MIGENIX CORP. | 2001-11-22 | — | — | US | disclosed |
| WO-2000026370-A9 | ADENINE NUCLEOTIDE TRANSLOCATOR (ANT) FUSION PROTEINS AND USES THEREOF | MITOKOR (US) | 2001-11-15 | — | — | WO | disclosed |
| WO-2001085944-A2 | PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR | MITOKOR (US) | 2001-11-15 | — | — | WO | disclosed |
| EP-1049780-A1 | ADENINE NUCLEOTIDE TRANSLOCATOR (ANT) FUSION PROTEINS AND USES THEREOF | MITOKOR (US) | 2000-11-08 | — | — | EP | disclosed |
| WO-2000026370-A2 | ADENINE NUCLEOTIDE TRANSLOCATOR (ANT) FUSION PROTEINS AND USES THEREOF | MITOKOR (US) | 2000-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010044144-A1 | Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor | GART, TMEM165, SLC43A3 | ESR1 3311/4885ESR2 3727/4885SRC 4827/4885 |
| US-20050003353-A1 | PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR | GART, TMEM165, SLC43A3 | ESR1 3311/4885ESR2 3727/4885SRC 4827/4885 |
| US-20040241801-A1 | Production of adenine nucleotide translocator (ANT), novel ANT ligands and screening assays therefor | GART, TMEM165, SLC43A3 | ESR1 3311/4885ESR2 3727/4885SRC 4827/4885 |
| US-20050003352-A1 | PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR | GART, TMEM165, SLC43A3 | ESR1 3311/4885ESR2 3727/4885SRC 4827/4885 |
| US-20050064530-A1 | PRODUCTION OF ADENINE NUCLEOTIDE TRANSLOCATOR (ANT), NOVEL ANT LIGANDS AND SCREENING ASSAYS THEREFOR | GART, TMEM165, SLC43A3 | ESR1 3311/4885ESR2 3727/4885SRC 4827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.